Navigating the realm of end-of-life care and access to medications like Pentobarbital in New South Wales, NSW, requires a careful understanding of the detailed legal framework. Currently, Pentobarbital does not have a approved place on the Pharmaceutical Benefits Scheme (this program) and is therefore not routinely prescribed by healthcare professi